HomeCompareBFFTF vs XYLD

BFFTF vs XYLD: Dividend Comparison 2026

BFFTF yields 606.06% · XYLD yields 10.98%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BFFTF wins by $280371.14M in total portfolio value
10 years
BFFTF
BFFTF
● Live price
606.06%
Share price
$0.33
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$280371.17M
Annual income
$211,667,981,687.60
Full BFFTF calculator →
XYLD
Global X S&P 500 Covered Call ETF
● Live price
10.98%
Share price
$39.13
Annual div
$4.30
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.3K
Annual income
$3,219.02
Full XYLD calculator →

Portfolio growth — BFFTF vs XYLD

📍 BFFTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBFFTFXYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BFFTF + XYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BFFTF pays
XYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BFFTF
Annual income on $10K today (after 15% tax)
$51,515.15/yr
After 10yr DRIP, annual income (after tax)
$179,917,784,434.46/yr
XYLD
Annual income on $10K today (after 15% tax)
$933.63/yr
After 10yr DRIP, annual income (after tax)
$2,736.17/yr
At 15% tax rate, BFFTF beats the other by $179,917,781,698.29/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BFFTF + XYLD for your $10,000?

BFFTF: 50%XYLD: 50%
100% XYLD50/50100% BFFTF
Portfolio after 10yr
$140185.60M
Annual income
$105,833,992,453.31/yr
Blended yield
75.50%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BFFTF right now

BFFTF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
-7.4
Piotroski
2/9
XYLD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BFFTF buys
0
XYLD buys
0
No recent congressional trades found for BFFTF or XYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBFFTFXYLD
Forward yield606.06%10.98%
Annual dividend / share$2.00$4.30
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$280371.17M$25.3K
Annual income after 10y$211,667,981,687.60$3,219.02
Total dividends collected$274648.71M$19.6K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: BFFTF vs XYLD ($10,000, DRIP)

YearBFFTF PortfolioBFFTF Income/yrXYLD PortfolioXYLD Income/yrGap
1← crossover$71,306$60,606.06$10,818$1,098.39+$60.5KBFFTF
2$480,183$403,885.93$11,738$1,222.51+$468.4KBFFTF
3$3,055,680$2,541,883.57$12,774$1,364.64+$3.04MBFFTF
4$18,386,820$15,117,242.14$13,944$1,527.86+$18.37MBFFTF
5$104,687,331$85,013,433.96$15,270$1,715.87+$104.67MBFFTF
6$564,382,839$452,367,394.46$16,775$1,933.09+$564.37MBFFTF
7$2,883,114,581$2,279,224,943.60$18,490$2,184.87+$2883.10MBFFTF
8$13,966,501,456$10,881,568,854.67$20,450$2,477.63+$13966.48MBFFTF
9$64,208,586,900$49,264,430,341.75$22,697$2,819.19+$64208.56MBFFTF
10$280,371,169,670$211,667,981,687.60$25,280$3,219.02+$280371.14MBFFTF

BFFTF vs XYLD: Complete Analysis 2026

BFFTFStock

Biofrontera AG, a biopharmaceutical company, engages in the research, development, and marketing of dermatological products. Its products include Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. The company also develops RhodoLED XL for the treatment of multiple interspersed lesions; Belixos, a modern active cosmetic product for irritated and sensitive skin; and Xepi for the treatment of antibiotic-resistant bacteria. It offers its products primarily in the United States, Europe, and Israel. The company has a collaboration and partnership agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.

Full BFFTF Calculator →

XYLDETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →
📬

Get this BFFTF vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BFFTF vs SCHDBFFTF vs JEPIBFFTF vs OBFFTF vs KOBFFTF vs MAINBFFTF vs QYLDBFFTF vs JEPQBFFTF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.